Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
  • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
  • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
  • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D263/18—Oxygen atoms
  • C07D263/20—Oxygen atoms attached in position 2
  • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/42—Oxazoles
  • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
  • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
  • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
  • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/20—Pills, tablets, discs, rods

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Medicinal Chemistry (AREA)
• Animal Behavior & Ethology (AREA)
• Life Sciences & Earth Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Epidemiology (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Pain & Pain Management (AREA)
• Neurology (AREA)
• Orthopedic Medicine & Surgery (AREA)
• Physical Education & Sports Medicine (AREA)
• Rheumatology (AREA)
• Medicinal Preparation (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=52393794

Family Applications (2)

Family Applications Before (1)

Country Status (18)

Families Citing this family (2)

Family Cites Families (11)

• 2014
  • 2014-07-22 BR BR112016001395A patent/BR112016001395A8/en not_active IP Right Cessation
  • 2014-07-22 MX MX2016001019A patent/MX365591B/en active IP Right Grant
  • 2014-07-22 SG SG11201600264TA patent/SG11201600264TA/en unknown
  • 2014-07-22 CN CN201480041432.5A patent/CN105431136B/en not_active Expired - Fee Related
  • 2014-07-22 US US14/906,703 patent/US20160159756A1/en not_active Abandoned
  • 2014-07-22 MY MYPI2016700223A patent/MY181226A/en unknown
  • 2014-07-22 SG SG10201800491RA patent/SG10201800491RA/en unknown
  • 2014-07-22 JP JP2016529842A patent/JP6453876B2/en not_active Expired - Fee Related
  • 2014-07-22 WO PCT/US2014/047701 patent/WO2015013336A1/en active Application Filing
  • 2014-07-22 RU RU2016105763A patent/RU2684914C2/en active
  • 2014-07-22 AU AU2014293193A patent/AU2014293193A1/en not_active Abandoned
  • 2014-07-22 DK DK14830224.3T patent/DK3024440T3/en active
  • 2014-07-22 CA CA2918908A patent/CA2918908A1/en not_active Abandoned
  • 2014-07-22 KR KR1020167001873A patent/KR20160039608A/en not_active Application Discontinuation
  • 2014-07-22 EP EP14830224.3A patent/EP3024440B1/en not_active Not-in-force
• 2016
  • 2016-01-03 IL IL243447A patent/IL243447A0/en unknown
  • 2016-01-19 ZA ZA2016/00408A patent/ZA201600408B/en unknown
  • 2016-01-22 CL CL2016000171A patent/CL2016000171A1/en unknown
  • 2016-09-13 HK HK16110813.6A patent/HK1222570A1/en unknown
  • 2016-12-01 HK HK16113682A patent/HK1225301A1/en not_active IP Right Cessation
• 2017
  • 2017-09-05 US US15/696,125 patent/US20180148422A1/en not_active Abandoned
• 2018
  • 2018-11-13 US US16/190,104 patent/US20190152930A1/en not_active Abandoned
• 2020
  • 2020-05-15 US US16/875,931 patent/US20210101873A1/en not_active Abandoned
• 2022
  • 2022-02-07 US US17/666,465 patent/US20220235017A1/en not_active Abandoned
• 2023
  • 2023-07-12 US US18/221,353 patent/US20240150304A1/en active Pending

Also Published As

Similar Documents